CASE REPORTS IN ONCOLOGY, vol.3, no.3, pp.480-488, 2010 (ESCI)
Article / Article
CASE REPORTS IN ONCOLOGY
Emerging Sources Citation Index (ESCI), Scopus
Cetuximab, Head and neck carcinoma, Irradiation, Radiotherapy, Recurrence
Gazi University Affiliated:
We presented 9 recurrent head and neck carcinoma patients. Priorly all of them had received radiochemotherapy. We used cetuximab and irradiation concomitantly. Overall survival analysis of the patients was performed using the Kaplan-Meier method on SPSS version 15.0. Based on this calculation, mean follow-up duration is 12.8 months. Mean survival time is 19.8 months and annual mean survival rate is 59.3%.